Licencing, Development, Support and Maintenance

Nhs Blood & TransplantcontractContracts FinderRef tender_224033/850099SME suitablecomplete
View buyer

Estimated value

£2.6m

Awarded value

£2.6m

Awarded 02 Apr 2020

Suppliers

1

Lots

1

1 awarded

Published

18 May 2020

Deadline 10 Jan 2020

Description

Hematos is a blood donor and patient testing system, supporting the bulk of NHSBT's Diagnostic and Therapeutic Services (DTS) Directorate. As a system it records immuno‐genetic test data including HLA and HPA types to support all of the DTS "Specialist Services" functions: Red Cell Immunohaematology, International Blood Group Reference Laboratory, Histocompatibility and Immunogenetics, Cellular and Molecular Therapies, Stem Cell Donation and Transplantation (SCDT). Hematos additionally supports the National Bacteriology Laboratory (NBL). In the SCDT function Hematos is used to support the collection, processing and distribution of stem cell and cord blood products and the creation and maintenance of a searchable registry of potential adult bone marrow/stem cell donors and a searchable bank of cord blood donations. As a system it records immuno‐genetic test data including red cell, HLA and HPA types. Hematos is critical to all aspects of business as usual within DTS, and to the delivery of the strategic plans for 2014-20. The requirement of this tender is for the ongoing provision of support and, in response to changing business circumstances such as new/amended regulations, maintenance services for these systems.

Scope

Reference
tender_224033/850099
Total value
£2,643,941 excluding VAT
Commercial tool
Standalone contract
Contract dates
31 Mar 2020 to 30 Mar 2023
CPV classifications
48000000 48100000 48180000
Particular suitability
Small and medium-sized enterprises (SME)

Submission & procedure

Submission deadline
10 Jan 2020, 12:00 am

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£2.6m

Award date

02 Apr 2020

Contract start

31 Mar 2020

Contract end

30 Mar 2023

Awarded to